Showing results (521-530 of 722) with videos related to

Sort By:
Pageof 73
The Lancet. Haematology|October 4, 2023
Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO): extended follow up of an open-label, randomised, multicentre, phase 3 trialMeletios A Dimopoulos, Evangelos Terpos, Mario Boccadoro, et al.
The Lancet. Haematology|October 10, 2024
Maternal and obstetric outcomes in women with pregnancy-associated haematological malignancies: an observational nationwide cohort studyPierre Pinson, Ismael Boussaid, Justine Decroocq, et al.
The Lancet. Haematology|September 9, 2024
Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trialGordon Cook, A John Ashcroft, Ethan Senior, et al.
The Lancet. Haematology|June 1, 2023
Immunochemotherapy for life-threatening haematological malignancies in pregnancy: a systematic review of the literature and cross-sectional analysis of clinical trial eligibilityGeorgia S Mills, Verity Chadwick, Catherine Tang, et al.
The Lancet. Haematology|June 12, 2026
Epcoritamab monotherapy or epcoritamab with lenalidomide as first-line therapy for patients with diffuse large B-cell lymphoma (EPCORE DLBCL-3): primary analysis of an open-label, multicentre, randomised, phase 2 trialUmberto Vitolo, Juan Miguel Bergua Burgues, Johannes Duell, et al.
The Lancet. Haematology|June 4, 2026
Donor cell-derived haematological neoplasms after allogeneic haematopoietic cell transplantation: recommendations from the EBMT Practice Harmonisation and Guidelines CommitteeCarmelo Gurnari, Chris Armstrong, Giorgia Battipaglia, et al.
The Lancet. Haematology|June 4, 2026
Diagnosis of primary CNS lymphoma through molecular and immune biomarkers in cerebrospinal fluid (PRICELUS): a multicentre, prospective, cohort studyJosephus L M van Rooij, Peter H Wessels, Johanna M Niers, et al.
The Lancet. Haematology|July 30, 2023
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 studyAaron T Gerds, Srdan Verstovsek, Alessandro M Vannucchi, et al.
The Lancet. Haematology|July 14, 2023
Sickle cell disease landscape and challenges in the EU: the ERN-EuroBloodNet perspectiveMaría Del Mar Mañú Pereira, Raffaella Colombatti, Federico Alvarez, et al.
The Lancet. Haematology|July 2, 2026
Autologous and allogeneic haematopoietic cell transplantation in adult patients with Hodgkin lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee and Lymphoma Working PartyAli Bazarbachi, Ranjana Advani, Sairah Ahmed, et al.
Pageof 73